Apogee Therapeutics, Inc. (APGE) research
Apogee Therapeutics, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $135.07
- As of
Kresmion compiles this page from APGE's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Apogee Therapeutics, Inc. (APGE): 7 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-03.
As of . Source: SEC EDGAR filings for APGE. Method and limitations.
Share the APGE intelligence card
See the full APGE dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for APGE on one page. Preview it with sample data, then open it live with a free account.
Preview the APGE dossierActive signals for APGE
- highCONSENSUS_SELL
4 tracked funds reduced APGE this 2026Q2, institutional consensus
- highCONSENSUS_BUY
6 tracked funds increased APGE this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +178% to APGE (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 56% of APGE (2026Q2)
- highCONSENSUS_BUY
5 tracked funds increased APGE this 2026Q2, institutional consensus
FREE, NO ACCOUNT
Every signal on APGE, as it fires
You are seeing 5 of 14 signals recorded on APGE since 2026-07-23.
The five above landed across 2 days. The other 9 were recorded on 1 other days. 9 of the 14 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in APGE (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 03770N101 · 2026Q2 | $198M | 0.07% | , |
| SOROS FUND MANAGEMENT LLCCUSIP 03770N101 · 2026Q2 | $74.9M | 0.92% | , |
| D. E. Shaw & Co., Inc.CUSIP 03770N101 · 2026Q2 | $32.7M | 0.02% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 03770N101 · 2026Q2 | $19.5M | 0.03% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 03770N101 · 2026Q2 | $12.6M | 0.01% | , |
| Point72 Asset Management, L.P.CUSIP 03770N101 · 2026Q2 | $7.2M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 03770N101 · 2026Q2 | $5.8M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, APGE
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Follow APGE on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to APGE for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.